2nd Annual
2008 BIOPHARMA OUTSOURCING:
Partnerships with CROs and Service Providers

Bringing the Buyers & Sellers of Outsourcing Services Together –
From Discovery to Clinical Trials

March 25-26, 2008 • Hilton Boston Back Bay • Boston, MA

BioPharma Outsourcing Partnerships: How to Win The End Game

Who will win the end game in this post blockbuster drug era? Find out from the buyers and sellers who are at the forefront of scientific research and development and business strategy. Meet and learn from a variety of experts who are reaping the rewards of this surge in contract services.

The BioPharma Outsourcing market continues to drive innovation and growth for big and mid-sized pharma. CROs and CMOs have become an invaluable asset to all categories engaged in the manufacture, research and development and marketing of drugs. However, pharmacovigilance and the threat of generics continue to pose new challenges to both sides of the alliance. Learn about some new developments and strategies including outsourcing to companies that are local at this year’s iiBIG Boston forum. Find out the new equations in deal-making and ways to empower your strategic partnerships with CROs/CMOs and other biotech and pharmaceutical teams.

Distinguished Speaker Roster Includes (subject to change… updated as of February 27, 2008):

  • Diana M. Galer Ph.D., VP, Strategic Management Group,
    Pfizer Global Research & Development
  • Christine T. Fischette, Ph.D., President,
    Enzo Therapeutics
  • Mark Tracy, Senior Director, Pharmaceutical Operations, Alnylam Pharmaceuticals
  • Mel Sorensen, M.D., President & CEO,
    Ascenta Therapeutics, Inc.
  • Ahsan Awan, JD, MBA, CRCP,
    Global CINRG, Inc.
  • Gur Roshwalb, MD, VP & Senior Analyst Health Care,
    Piper Jaffray & Co.
  • Han Gunn, Preclinical Director, Department of Pharmacokinetics & Drug Metabolism, Amgen
  • Partha S. Ray, MD, CEO,
    IndusPharma Consulting Group
  • Michael Palladino, PhD, Senior VP, CTO, & Scientific Co-Founder, Nereus Pharmaceuticals
  • Steve J. Bannister, PhD, Chief Scientific Officer,
    Xcelience, LLC
  • Judd Berman, PhD., Chief Scientific Officer,
    Dalton Medicinal Chemistry
  • Zhengming (Jimmy) Chen, PhD, Senior Director, Chemistry and CMC, DOV Pharmaceutical, Inc.
  • K.George Mooney, President,
    KGM Pharma Consulting LLC
    (formerly VP, R&D of Pfizer Global)
  • Steven Tregay, Managing Director,
    Novartis Option Fund
  • David Phillips, Senior VP, Sales and Marketing,
    BioFocus DPI Limited (a Galapagos Company)
  • Al Correia, VP, Operations,
    Cambridge Biomedical Research Group
  • Judith Gwathmey, Founder, President & CSO,
    Gwathmey Inc.
  • Julia H. Riley, DVM, MS (Pathology), Diplomate American College of Veterinary Pathologists, Diplomate American Board of Toxicology, Head of Biologics division, xFDA LLC
  • Ravi Kiron, PhD, MBA, Chief Operating Officer,
    LifeTech Innovations, LLC
  • Patrick G. Atari, Partner,
    McDonnell Boehnen Hulbert & Berghoff LLP
  • Jim Prescott, Director, Analytical Chemistry,
    MicroCHIPS, Inc.
  • Mark A. Staples, Consultant,
    Pharmaceutical Technology Solutions
    (formerly VP, R&D of MicroCHIPS, Inc.)
  • Sasha Damouni, Editor,
    Pharmawire
  • Philip Borden, Principal,
    Riverside Partners
  • Babu Nema Head New Initiatives,
    Tata Consultancy Services, India
  • Dean Wilson, PhD, Research Fellow,
    Vertex Pharmaceuticals
  • Janet Wolfe, Ph.D., President,
    Wolfe Laboratories

Participate in the Conference Discourse Involving:

  • Strategic Innovation in Biotech Partnerships
  • The Evolution of Complex Strategic Alliances – Where is Big Pharma Headed?
  • Innovation Through Outsourcing – More Than a Promise
  • Outsourcing Discovery Chemistry: How Does it Work?
  • Identifying the Right CRO and Shepherding a Product in Preclinical
  • What It Means to Go Global: Understanding Diverse Alliances, Partnerships and Platforms
  • Evaluating International Outsourcing and Risks – The BIG Picture
  • Local Outsourcing – Interactivity a Key Element in a Dynamic Environment
  • Investment and M& A Outlook for the BioPharma Industry – Opportunities for Companies with Outsourcing Business Models
  • Creating a Unified Drug Safety and Pharmacovigilance Environment
  • Biogenerics – Evolving Risks and Opportunities for Biopharmaceutical, Generic and Contract Manufacturers
  • Transforming R&D and Clinical Through eClinical Technology Partnerships and Alliances
  • Managing for Performance: Drug Discovery Case Study
  • Protein Bioanalysis: Building a Partnership from the Ground Up

PRICING:
$1895: CRO/CMO & Other Service Provider Rate
Register a team of 3 or more at the same time for $1,395 per person – no deadline!

$1495: Pharma/Biotech Outsourcing Sponsor Rate
Register a team of 3 or more at the same time for $995 per person – no deadline!

FOR CONFERENCE UPDATES AND REGISTRATION INFORMATION
Call: 212-300-2523 • Email: info@iiBIG.com • Visit: www.iiBIG.com/P0803

DON'T MISS OUT ON THESE OPPORTUNITIES:

Industry Leaders Welcome –
Speaking Opportunities:
iiBIG receives more requests to speak at our conferences than we have slots available. Agendas consist of workshops, panel discussions, case studies and stand-alone presentations; and curricula are designed with input from steering committees made up of the target industries’ leading executives. Overtly commercial presentations are not permitted, however if you would like to propose an information-rich topic on which you would like to present, please submit your details to iiBIG’s research consultant and Program Advisory team leader:

Rupa Ranganathan, Founder, Executive Research Institute International, LLC &
Strategic Advisor to iiBIG
E-mail: rupar@iibig.com
Call: 973-722-7848

Sponsorship and Exhibiting Opportunities Available:
As a business development opportunity, this conference will provide networking and showcase opportunities second-to-none. To enhance your company’s brand, call us to discuss the various ways you can highlight the solutions your company offers to key decision-makers in this field – including, if appropriate, a role on the speaking faculty, please contact:

Kellie Swanstrom, VP,
Business Development, iiBIG
E-mail: kellies@iibig.com
Call: 973-571-0867

Marketing Partnerships:
For more information on reciprocal co-marketing opportunities associated with this conference, please contact:

Ria Lubis, VP, Marketing, iiBIG
E-mail: rial@iibig.com
Call: 212-300-2523
     
     
     

© 2006 - 2007 INTERNATIONAL INSTITUTE FOR BUSINESS INFORMATION & GROWTH, LLC. All rights reserved.